BeStock  
Stocks › PHAR

Pharming Group PHAR

US equityMarket cap rank #3529
$9.65 −$0.03 (-0.31%)
Pre-market · Oct 8, 9:00 am ET · After hours $9.65 0.00%
Open$9.65
Prev close$9.68
Day range$9.59 – $9.75
Volume3,833
Market cap$683.01M
P/E (TTM)68.9
Dividend yield–

Earnings

Average move on report day±8.6%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+12.9%
Worst reaction-26.8%

Stock move on the day after each report

+5.0%2023/Q3-1.7%2023/Q4-1.7%2024/Q1-8.4%2024/Q2-7.4%2024/Q3+12.9%2024/Q4+11.2%2025/Q1+10.1%2025/Q2+11.5%2025/Q3-4.7%2025/Q4-26.8%2026/Q1-10.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q230 Jul 2026Pre Market–-10.49%–
2026/Q17 May 2026Pre Market–-26.83%–
2025/Q412 Mar 2026Pre Market–-4.66%–
2025/Q36 Nov 2025Pre Market–+11.53%–
2025/Q231 Jul 2025Pre Market–+10.11%–
2025/Q18 May 2025None–+11.22%–
2024/Q413 Mar 2025Pre Market–+12.92%–
2024/Q324 Oct 2024None–-7.37%–
2024/Q21 Aug 2024None–-8.40%–
2024/Q18 May 2024None–-1.66%–
2023/Q414 Mar 2024None–-1.71%–
2023/Q326 Oct 2023Pre Market–+5.00%–
2023/Q23 Aug 2023None–+4.17%–
2023/Q111 May 2023None–-20.36%–
2022/Q416 Mar 2023None–-1.56%–
2022/Q327 Oct 2022None–+0.00%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q1

By business line

  • RUCONEST$58.40M 80.6%
  • Joenja$14.10M 19.4%

Latest reported quarter: Q2, ended Jun 2026

Revenue$90.21M-3.2% YoY
Operating profit-$111,000.00-101.2% YoY
Net profit$1.64M-64.0% YoY
Diluted EPS$0.02-66.9% YoY
Free cash flow-$9.74M-183.9% YoY
Operating cash flow-$9.66M

Revenue, last 8 quarters

$74.8MSep '24$92.7MDec '24$79.1MMar '25$93.2MJun '25$97.3MSep '25$106.5MDec '25$72.4MMar '26$90.2MJun '26

Net profit, last 8 quarters

$-1.0MSep '24$2.9MDec '24$-14.9MMar '25$4.6MJun '25$7.5MSep '25$5.3MDec '25$-5.2MMar '26$1.6MJun '26

Profitability & balance sheet

Gross margin86.5%
Operating margin3.8%
Net margin2.5%
Return on equity3.6%
Return on assets2.0%
Return on invested capital4.1%
Current ratio3.01
Liabilities / assets42.2%
Cash & investments$158.28M
Total debt$109.72M
Net cash (debt)$48.56M
Free cash flow / sales9.4%

Discussion

No comments yet — be the first to weigh in on PHAR.

Leave a comment

Scroll to Top